Chen Q Y, Li N, Jiang J
Department of Colorectal Disease, Shanghai Tenth People's Hospital, Clinical Research Center for Digestive Diseases, Tongji University, Shanghai 200072, China.
Institute of General Surgery, East War Zone Hospital of PLA, Nanjing 210002, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Dec 25;24(12):1048-1053. doi: 10.3760/cma.j.cn441530-20210921-00377.
The role of the brain-gut microbiota axis in functional gastrointestinal diseases has been gradually recognized. According to the ROME IV diagnostic criteria, functional gastrointestinal diseases are classified as diseases caused by abnormal brain-gut interaction. This concept is of great significance to the change of diagnosis and treatment paradigm of functional gastrointestinal diseases. Chronic constipation is the most common functional gastrointestinal disease. The pathogenesis of chronic constipation is closely related to the imbalance of intestinal flora, the abnormality of enteric nervous system and neurotransmitter in brain. Therefore, in the diagnosis and treatment of chronic constipation, enough attention should be paid to the concept of integration of brain-gut microflora axis, but the clinical application of brain-gut microflora axis is still limited. This may be one of the factors for high incidence but poor treatment efficacy of chronic constipation. Based on the global research progress and our clinical experience, this article expounds the clinical significance of the brain-gut microbiota axis in chronic constipation.
脑-肠微生物群轴在功能性胃肠疾病中的作用已逐渐得到认可。根据罗马IV诊断标准,功能性胃肠疾病被归类为由脑-肠相互作用异常引起的疾病。这一概念对功能性胃肠疾病诊疗模式的转变具有重要意义。慢性便秘是最常见的功能性胃肠疾病。慢性便秘的发病机制与肠道菌群失衡、肠神经系统及脑中神经递质异常密切相关。因此,在慢性便秘的诊治中,应充分重视脑-肠微生物群轴的概念,但脑-肠微生物群轴的临床应用仍较为有限。这可能是慢性便秘发病率高但治疗效果不佳的因素之一。基于全球研究进展及我们的临床经验,本文阐述脑-肠微生物群轴在慢性便秘中的临床意义。